Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Maravai Lifesciences Holdings (MRVI) Return on Equity (2021 - 2025)

Maravai Lifesciences Holdings has reported Return on Equity over the past 5 years, most recently at 0.75% for Q4 2025.

  • Quarterly results put Return on Equity at 0.75% for Q4 2025, down 31.0% from a year ago — trailing twelve months through Dec 2025 was 0.75% (down 31.0% YoY), and the annual figure for FY2025 was 0.49%, down 11.0%.
  • Return on Equity for Q4 2025 was 0.75% at Maravai Lifesciences Holdings, down from 0.6% in the prior quarter.
  • Over the last five years, Return on Equity for MRVI hit a ceiling of 0.96% in Q2 2021 and a floor of 0.89% in Q2 2025.
  • Median Return on Equity over the past 5 years was 0.13% (2023), compared with a mean of 0.13%.
  • Biggest five-year swings in Return on Equity: grew 19bps in 2022 and later tumbled -73bps in 2023.
  • Maravai Lifesciences Holdings' Return on Equity stood at 0.94% in 2021, then tumbled by -40bps to 0.56% in 2022, then plummeted by -129bps to 0.16% in 2023, then crashed by -165bps to 0.44% in 2024, then crashed by -71bps to 0.75% in 2025.
  • The last three reported values for Return on Equity were 0.75% (Q4 2025), 0.6% (Q3 2025), and 0.89% (Q2 2025) per Business Quant data.